BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16941571)

  • 1. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
    Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
    Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
    Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
    Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
    He H; Sun G; Ping F
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.
    Suriano R; Lin Y; Ashok BT; Schaefer SD; Schantz SP; Geliebter J; Tiwari RK
    J Proteome Res; 2006 Apr; 5(4):856-61. PubMed ID: 16602693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of papillary thyroid carcinoma with serum protein profile analysis.
    Moretz WH; Gourin CG; Terris DJ; Xia ZS; Liu Z; Weinberger PM; Chin E; Adam BL
    Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):198-202. PubMed ID: 18283164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis.
    Mao Y; Yu J; Chen J; Yang H; He Q; Shou Z; Wu J; Zheng S
    Transpl Immunol; 2008 Jan; 18(3):255-9. PubMed ID: 18047934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fine needle aspiration biopsy in the diagnosis of thyroid neoplasms].
    Ravetto C
    Chir Ital; 1994; 46(4):8-11. PubMed ID: 7882452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
    Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
    Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
    Belousov PV; Bogolyubova AV; Kim YS; Abrosimov AY; Kopylov AT; Tvardovskiy AA; Lanshchakov KV; Sazykin AY; Dvinskikh NY; Bobrovskaya YI; Selivanova LS; Shilov ES; Schwartz AM; Shebzukhov YV; Severskaia NV; Vanushko VE; Moshkovskii SA; Nedospasov SA; Kuprash DV
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1206-15. PubMed ID: 26196948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcarcinoma of the thyroid.
    Baloch ZW; LiVolsi VA
    Adv Anat Pathol; 2006 Mar; 13(2):69-75. PubMed ID: 16670460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Using ANN and serum protein pattern models in liver cancer diagnosis].
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):189-92. PubMed ID: 15854466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokeratins determination in differentiated thyroid carcinoma.
    Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
    J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.